Generics Get Boost From PBMs' Cost-Cutting Strategies

Drug Industry Daily
KEYWORDS generic / Markets
A A

Express Scripts reportedly plans to ask clients to drop Pfizer’s Lipitor from preferred drug lists in favor of Merck’s soon-to-be-off-patent Zocor — the latest move by pharmaceutical benefit managers (PBMs) to supply their clients with more generic drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily